Page 164 - 南京医科大学学报自然科学版
P. 164
第41卷第7期
·1094 · 南 京 医 科 大 学 学 报 2021年7月
2016,351(6280):1463-1469 [84] HONG L,NEGRAO M V,DIBAI S S,et al. Programmed
[80] TUMEH P C,HARVIEW C L,YEARLEY J H,et al. PD⁃ death ⁃ ligand 1 heterogeneity and its impact on benefit
1 blockade induces responses by inhibiting adaptive im⁃ from immune checkpoint inhibitors in NSCLC[J]. J Tho⁃
mune resistance[J]. Nature,2014,515(7528):568-571 rac Oncol,2020,15(9):1449-1459
[81] GAINOR J F,SHAW A T,SEQUIST L V,et al. EGFR mu⁃ [85] ZHAO P,LI L,JIANG X,et al. Mismatch repair deficien⁃
tations and ALK rearrangements are associated with low cy/microsatellite instability⁃high as a predictor for anti⁃PD
response rates to PD ⁃ 1 pathway blockade in non ⁃ small ⁃1/PD⁃L1 immunotherapy efficacy[J]. J Hematol Oncol,
cell lung cancer:a retrospective analysis[J]. Clin Cancer 2019,12(1):54
Res,2016,22(18):4585-4593 [86] WARTH A,KÖRNER S,PENZEL R,et al. Microsatellite
[82] BITON J,MANSUET ⁃ LUPO A,PÉCUCHET N,et al. instability in pulmonary adenocarcinomas:a comprehen⁃
TP53,STK11,and EGFR mutations predict tumor im⁃ sive study of 480 cases[J]. Virchows Arch,2016,468
mune profile and the response to anti⁃PD⁃1 in lung adeno⁃ (3):313-319
carcinoma[J]. Clin Cancer Res,2018,24(22):5710- [87] VANDERWALDE A,SPETZLER D,XIAO N,et al. Mic⁃
5723 rosatellite instability status determined by next ⁃ genera⁃
[83] GUBENS M A,DAVIES M. NCCN guidelines updates: tion sequencing and compared with PD⁃L1 and tumor mu⁃
new immunotherapy strategies for improving outcomes in tational burden in 11 348 patients[J]. Cancer Med,2018,
non⁃small cell lung cancer[J]. J Natl Compr Canc Netw, 7(3):746-756
2019,17(5.5):574-578 [收稿日期] 2020-02-12
欢迎投稿 欢迎订阅